Skip to main content
Top

Clinical & Experimental Metastasis

Issue 6/2019

Content (8 Articles)

Care Editorial

Editorial series: cancer care in low- and middle-income countries

Jörg Haier, Jonathan Sleeman, Jürgen Schäfers

Prostate Cancer Research Paper

Metastatic dissemination patterns of different primary tumors to the spine and other bones

Julia S. Onken, Lucius S. Fekonja, Romy Wehowsky, Vanessa Hubertus, Peter Vajkoczy

Metastasis Research Paper

Ureteral involvement by metastatic malignant disease

Jieping Hu, Jun Deng, Ju Guo, Bin Fu

Open Access Autopsy Research Paper

Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei

Olaf Sørensen, Anders Mikal Andersen, Stein Gunnar Larsen, Karl-Erik Giercksky, Kjersti Flatmark

Open Access Glioma Research Paper

NHE5 regulates growth factor signaling, integrin trafficking, and degradation in glioma cells

Toru Kurata, Vinotheni Rajendran, Steven Fan, Tetsuo Ohta, Masayuki Numata, Sachio Fushida

Breast Cancer Research Paper

Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization

Ryo Fujita, Hiroki Hamano, Yusuke Kameda, Ryuta Arai, Tomohiro Shimizu, Masahiro Ota, Dai Sato, Hideyuki Kobayashi, Norimasa Iwasaki, Masahiko Takahata

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine